ZYXI Stock Price, Chart, Stats & News

Zynex, Inc.
Save
3.80M
Market cap
–
Current P/E
16.61x
Forward P/E
ZYXI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 71.64% |
Operating margin | -62.76% |
Pretax margin | -65.57% |
Net margin | -68.35% |
Effective tax rate | -4.24% |
ROA | -163.18% |
ROE | -1807.05% |
D/E | -1.73x |
Interest coverage ratio | -22.32x |
ZYXI valuation
P/E | – |
P/S | 0.02x |
P/B | -0.04x |
P/CF | -0.08x |
P/FCF | -0.08x |
P/OCF | -0.08x |
PEG | 0.00x |
EV multiple | 0.88x |
About
Zynex, Inc., operating through its subsidiaries, specializes in the development, production, and sale of medical devices. These devices primarily utilize electrical stimulation to alleviate both chronic and acute pain, and to stimulate and exercise muscles for rehabilitation. The company's core product offerings include NexWave, a versatile, dual-channel device combining interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES), which is actively marketed to physicians and therapists by its field sales force.
Similar securities
Based on sector and market capitalization
Report issue










